Getinge AB (publ) (GNGBY)
OTCMKTS · Delayed Price · Currency is USD
22.61
+0.02 (0.07%)
At close: Dec 12, 2025
Getinge AB Market Cap
Getinge AB has a market cap or net worth of $6.17 billion as of December 12, 2025. Its market cap has increased by 49.71% in one year.
Market Cap
6.17B
Enterprise Value
7.11B
Revenue
3.81B
Ranking
n/a
PE Ratio
28.29
Stock Price
$22.61
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 2.25B to 6.17B, an increase of 174.66%. That is a compound annual growth rate of 3.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 6.17B | 37.74% |
| Dec 30, 2024 | 4.48B | -26.09% |
| Dec 29, 2023 | 6.06B | 7.18% |
| Dec 30, 2022 | 5.65B | -52.49% |
| Dec 30, 2021 | 11.90B | 86.32% |
| Dec 30, 2020 | 6.39B | 25.58% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 827.70M |
| Elite Pharmaceuticals | 555.21M |
| Glass House Brands | 469.55M |
| CytoDyn | 413.90M |
| Northwest Biotherapeutics | 368.58M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 295.68M |
| Nika Pharmaceuticals | 290.99M |